Day 2 – Thursday, 17 September 2025Wednesday, September 17, 2025 - ET (Eastern Time, GMT-05:00)

In today’s competitive landscape, strategic alliances have become a critical component for growth and innovation. As large pharma seeks to maintain a competitive edge, partnerships with biotech firms, contract manufacturers, and academic institutions are pivotal to expanding capabilities, enhancing research, and bringing new treatments to market faster. This panel will explore the evolution of strategic alliances, offering insights into how industry leaders can forge and manage these collaborations effectively.

• From traditional licensing deals to innovative partnerships, what models are proving most effective in 2025?
• What makes a partnership truly strategic, and how can companies ensure they’re creating mutually beneficial relationships with biotech firms, academic institutions, and other stakeholders?
• cultural differences, regulatory hurdles, and differing business goals while maintaining a collaborative and forward-thinking approach
• How can large pharma companies leverage strategic partnerships to access emerging technologies, scale research, and speed up time to market?